Spleen to liver ratio (SLR): Novel PET imaging biomarker for prediction of overall survival after ipilimumab and anti-PD1 in patients with metastatic melanoma.

被引：7
|
作者：
Wong, Annie Ngai Man
Callahan, Jason
Beresford, Jenny
Herschtal, Alan
Fullerton, Sonia
Miine, Donna
Hicks, Rodney J.
McArthur, Grant A.
机构：
[1] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[2] Univ Melbourne, Melbourne, Vic, Australia
[3] Univ Melbourne, East Melbourne, Vic, Australia
[4] Peter MacCallum Canc Ctr, East Melbourne, Vic, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.9523
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9523
引用
收藏
页数：2
相关论文
共 50 条
  • [1] FDG PET biomarkers for prediction of survival in metastatic melanoma prior to anti-PD1 immunotherapy
    A. Flaus
    V. Habouzit
    N. De Leiris
    J. P. Vuillez
    M. T. Leccia
    J. L. Perrot
    N. Prevot
    F. Cachin
    Scientific Reports, 11
  • [2] FDG PET biomarkers for prediction of survival in metastatic melanoma prior to anti-PD1 immunotherapy
    Flaus, A.
    Habouzit, V
    De Leiris, N.
    Vuillez, J. P.
    Leccia, M. T.
    Perrot, J. L.
    Prevot, N.
    Cachin, F.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [3] Response to anti-PD1/PDL1 therapy in patients with metastatic desmoplastic melanoma.
    Eroglu, Zeynep
    Kim, Dae Won
    Johnson, Douglas Buckner
    Algazi, Alain Patrick
    Munhoz, Rodrigo Ramella
    Liniker, Elizabeth
    Kong, Ben
    Khurana, Neharika
    Chmielowski, Bartosz
    Sosman, Jeffrey Alan
    Scolyer, Richard A.
    Carlino, Matteo S.
    Postow, Michael Andrew
    Hwu, Wen-Jen
    Long, Georgina V.
    Ribas, Antoni
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] CIRCULATING TUMOR DNA AS A BIOMARKER IN METASTATIC MELANOMA PATIENTS TREATED WITH ANTI-PD1 ANTIBODIES
    Lee, J.
    Boyd, S.
    Tembe, V.
    Menzies, A.
    Long, G.
    Guminski, A.
    Kefford, R.
    Carlino, M.
    Rizos, H.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 48 - 49
  • [5] Toxicity and Survival for Metastatic Melanoma Patients Treated With Anti-PD1 Therapy and Radiation Treatment
    Mowery, Y. M.
    Patel, K.
    Olson, A. C.
    Khan, M. K.
    Salama, J. K.
    Salama, A. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S158 - S159
  • [6] Efficacy and safety of anti-PD1 monotherapy or in combination with ipilimumab after BRAF/MEK inhibitors in patients with BRAF mutant metastatic melanoma
    Pires da Silva, Ines
    Zakria, Danny
    Ahmed, Tasnia
    Trojanello, Claudia
    Dimitriou, Florentia
    Allayous, Clara
    Gerard, Camille
    Zimmer, Lisa
    Lo, Serigne
    Michielin, Olivier
    Lebbe, Celeste
    Mangana, Johanna
    Ascierto, Paolo Antonio
    Johnson, Douglas B.
    Carlino, Matteo
    Menzies, Alexander
    Long, Georgina
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (07)
  • [7] Clinical Factors Associated with Long-Term Survival in Metastatic Melanoma Treated with Anti-PD1 Alone or in Combination with Ipilimumab
    Goutam, Siddhartha
    Stukalin, Igor
    Ewanchuk, Benjamin
    Sander, Michael
    Ding, Philip Q.
    Meyers, Daniel E.
    Heng, Daniel
    Cheung, Winson Y.
    Cheng, Tina
    CURRENT ONCOLOGY, 2022, 29 (10) : 7695 - 7704
  • [8] Mechanisms of response to anti-PD1 (PD1) combined with Ipilimumab (IPI) in patients (pts) with PD1-resistant metastatic melanoma (MM)
    da Silva, Ines Pires
    Conway, Jordan
    Edwards, Jarem
    Marsh-Wakefield, Felix
    Quek, Camelia
    Ferguson, Angela
    Johnansson, Peter
    Carlino, Matteo
    Menzies, Alexander
    Wilmott, James
    Palendira, Umaimainthan
    Scolyer, Richard
    Long, Georgina
    CANCER RESEARCH, 2024, 84 (06)
  • [9] 18F-FDG PET/CT based spleen to liver ratio associates with clinical outcome to ipilimumab in patients with metastatic melanoma
    Wong, Annie
    Callahan, Jason
    Keyaerts, Marleen
    Neyns, Bart
    Mangana, Johanna
    Aberle, Susanne
    Herschtal, Alan
    Fullerton, Sonia
    Milne, Donna
    Iravani, Amir
    McArthur, Grant A.
    Hicks, Rodney J.
    CANCER IMAGING, 2020, 20 (01)
  • [10] 18F-FDG PET/CT based spleen to liver ratio associates with clinical outcome to ipilimumab in patients with metastatic melanoma
    Annie Wong
    Jason Callahan
    Marleen Keyaerts
    Bart Neyns
    Johanna Mangana
    Susanne Aberle
    Alan Herschtal
    Sonia Fullerton
    Donna Milne
    Amir Iravani
    Grant A. McArthur
    Rodney J. Hicks
    Cancer Imaging, 20
12345